1. Clinical Overview
A fixed-dose combination (FDC) product designed for the comprehensive management of functional gastrointestinal disorders (FGIDs) like Irritable Bowel Syndrome (IBS) and functional dyspepsia, particularly when associated with significant anxiety. It combines an anticholinergic/antispasmodic (Clidinium & Dicyclomine), an anxiolytic (Chlordiazepoxide), and an H2-receptor antagonist (Ranitidine). This combination aims to address the 'brain-gut axis' dysfunction by reducing visceral hypersensitivity, decreasing smooth muscle spasm, suppressing gastric acid, and alleviating anxiety. Its use is controversial and strictly regulated in India due to the presence of a benzodiazepine (chlordiazepoxide).
| Onset | Duration | Bioavailability |
|---|---|---|
| Clidinium/Dicyclomine: 1-2 hours; Chlordiazepoxide: 30-60 minutes; Ranitidine: 1-3 hours. | Clidinium/Dicyclomine: 4-6 hours; Chlordiazepoxide: 8-24 hours; Ranitidine: 8-12 hours. | Clidinium: ~90%; Chlordiazepoxide: ~100%; Dicyclomine: ~67%; Ranitidine: ~50% (subject to first-pass metabolism). |
2. Mechanism of Action
The combination exerts a multi-modal action. Clidinium and Dicyclomine competitively inhibit acetylcholine at muscarinic receptors in GI smooth muscle, reducing spasms, motility, and secretions. Chlordiazepoxide potentiates GABAergic inhibition in the CNS (limbic system, reticular formation), producing anxiolytic, sedative, and muscle relaxant effects, indirectly modulating the brain-gut axis. Ranitidine competitively inhibits histamine at H2 receptors on gastric parietal cells, reducing basal and stimulated gastric acid secretion.
3. Indications & Uses
- Irritable Bowel Syndrome (IBS) with predominant pain and bloating, accompanied by significant anxiety
- Functional dyspepsia with associated anxiety and hyperacidity symptoms
- Peptic ulcer disease (as adjunctive therapy for pain and anxiety during acute phase)
4. Dosage & Administration
Adult Dosage: One tablet two to three times daily, preferably before meals. The lowest effective dose for the shortest duration (typically not exceeding 2-3 weeks) should be used.
Administration: Take orally with a glass of water. Can be taken before meals to prevent meal-induced symptoms. Do not crush or chew. Avoid concomitant antacids within 1-2 hours as they may reduce Ranitidine absorption. Avoid alcohol completely.
5. Side Effects
Common side effects may include:
- Dry mouth (xerostomia)
- Drowsiness/sedation
- Blurred vision
- Constipation
- Dizziness/lightheadedness
- Headache
- Fatigue
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Alcohol, Opioids, Barbiturates, other CNS Depressants | Profound additive CNS and respiratory depression, sedation, risk of death. | Major |
| Potent CYP3A4 Inhibitors (Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | Markedly increased chlordiazepoxide levels, leading to excessive sedation and respiratory depression. | Major |
| Other Anticholinergics (Tricyclic Antidepressants, Antipsychotics, Antihistamines) | Additive anticholinergic toxicity: severe dry mouth, urinary retention, ileus, hyperthermia, confusion. | Major |
| Warfarin | Ranitidine may alter warfarin metabolism; monitor INR closely. | Moderate |
| Midazolam, Triazolam | Increased benzodiazepine levels and effects (CYP3A4 substrate). | Major |
| Levodopa | Anticholinergics may reduce gastric motility and absorption of levodopa, decreasing efficacy. | Moderate |
| Digoxin | Anticholinergics may increase digoxin absorption by reducing gut motility, risk of toxicity. | Moderate |
| Metoprolol, Propranolol | Ranitidine may increase bioavailability of some beta-blockers. | Moderate |
| Phenytoin | Ranitidine may inhibit metabolism, increasing phenytoin levels. | Moderate |
| Theophylline | Ranitidine may slightly increase theophylline levels. | Minor |
7. Patient Counselling
- DO take exactly as prescribed, do not increase dose or frequency.
- DO inform all your doctors and dentists you are taking this medicine.
- DO keep medicine in a secure place to prevent misuse by others.
- DO NOT stop taking this medicine suddenly; dose must be tapered under doctor's guidance to avoid withdrawal.
- DO NOT consume alcohol in any form.
- DO NOT take over-the-counter sleep aids, cough/cold medicines without consulting doctor.
8. Toxicology & Storage
Overdose: Manifestations of all four components: Profound CNS depression (somnolence, coma, respiratory arrest), severe anticholinergic crisis (hyperthermia, hot dry skin, flushed face, mydriasis, tachycardia, ileus, urinary retention, delirium, seizures), cardiovascular collapse.
Storage: Store below 30°C in a cool, dry place. Protect from light and moisture. Keep in the original blister pack or container. Keep out of reach and sight of children and adolescents. Dispose of unused tablets safely; do not flush. Return to pharmacy for disposal if possible.